COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE SECONDARY PREVENTION OF RECURRENT DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN THE UNITED KINGDOM

被引:1
|
作者
Wolowacz, S. [1 ]
Brockbank, J. [2 ]
Sunderland, T. J. [3 ]
Gonschior, A. K. [4 ]
机构
[1] RTI Hlth Solut, Manchester, Lancs, England
[2] RTI Hlth Solut, Didsbury, England
[3] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[4] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
关键词
D O I
10.1016/j.jval.2013.08.1280
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A526 / A526
页数:1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF STRATEGIES FOR MANAGEMENT OF DEEP VEIN THROMBOSIS
    Kostyuk, A.
    Akanov, A.
    Almadiyeva, A.
    VALUE IN HEALTH, 2015, 18 (03) : A140 - A140
  • [22] Deep vein thrombosis and pulmonary embolism: diagnosis, treatment and prevention
    Roberts, Lara N.
    Arya, Roopen
    CLINICAL MEDICINE, 2011, 11 (05) : 465 - 466
  • [23] Advances in the prevention and treatment of deep vein thrombosis and pulmonary embolism
    Grendys, EC
    Fiorica, JV
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1999, 11 (01) : 71 - 79
  • [24] Prevention of Deep Vein Thrombosis and Pulmonary Embolism in Patients With Stroke
    Field, Thalia S.
    Hill, Michael D.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (01) : 5 - 19
  • [25] PREVENTION OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM
    LEQUESNE, LP
    AMERICAN JOURNAL OF SURGERY, 1978, 135 (03): : 421 - 425
  • [26] Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism
    Motsch, Johann
    Walther, Andreas
    Bock, Matthias
    Boetiger, Bernd W.
    CURRENT OPINION IN ANESTHESIOLOGY, 2006, 19 (01) : 52 - 58
  • [27] Prevention of deep vein thrombosis and pulmonary embolism - The FDA responds
    Lutter, Randall
    McConagha, William A.
    PUBLIC HEALTH REPORTS, 2008, 123 (04) : 422 - 423
  • [28] Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis
    van Dam, Lisette F.
    van den Hout, Wilbert B.
    Gautam, Gargi
    Dronkers, Charlotte E. A.
    Ghanima, Waleed
    Gleditsch, Jostein
    von Heijne, Anders
    Hofstee, Herman M. A.
    Hovens, Marcel M. C.
    Huisman, Menno, V
    Kolman, Stan
    Mairuhu, Albert T. A.
    Nijkeuter, Mathilde
    van de Ree, Marcel A.
    van Rooden, Cornelis J.
    Westerbeek, Robin E.
    Westerink, Jan
    Westerlund, Eli
    Kroft, Lucia J. M.
    Klok, Frederikus A.
    BLOOD ADVANCES, 2021, 5 (05) : 1369 - 1378
  • [29] Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States
    LaMori, Joyce C.
    Shoheiber, Omar
    Mody, Samir H.
    Bookhart, Brahim K.
    CLINICAL THERAPEUTICS, 2015, 37 (01) : 62 - 70
  • [30] Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin:: Pulmonary Embolism Prevention (PEP) trial
    O'Brien, J
    Duncan, H
    Kirsh, G
    Allen, V
    King, P
    Hargraves, R
    Mendes, L
    Perera, T
    Catto, P
    Schofield, S
    Ploschke, H
    Hefner, T
    Churchland, M
    Woolnough, S
    Wuttke, R
    Manning, M
    Jeffries, T
    Hensley, L
    Bath, P
    Bainbridge, D
    Guinane, F
    McMahon, L
    Zavattaro, D
    Wilson, D
    Blake, K
    Morton, J
    Sharman, D
    Locke, R
    Ghabrial, J
    McNeil, S
    Rehfisch, P
    van der Merwe, S
    Einoder, B
    Douglas, D
    Ashwell, J
    Morrissey, A
    Brown, A
    Simm, R
    Fisch, G
    Crawford, W
    Everding, T
    Tanham, D
    Hooper, J
    Aldana, C
    Goldwasser, M
    Mibus, M
    Rowden, N
    Mills, J
    Johnson, P
    Stilwell, J
    LANCET, 2000, 355 (9212): : 1295 - 1302